A Phase 2 Trial of Talazoparib and Avelumab in Genomically Defined Metastatic Kidney Cancer
一项针对基因组定义的转移性肾癌的Talazoparib联合Avelumab的II期临床试验
期刊:European Urology Oncology
影响因子:9.3
doi:10.1016/j.euo.2023.10.017
Kotecha, Ritesh R; Doshi, Sahil D; Knezevic, Andrea; Chaim, Joshua; Chen, Yingbei; Jacobi, Rachel; Zucker, Mark; Reznik, Ed; McHugh, Deaglan; Shah, Neil J; Feld, Emily; Aggen, David H; Rafelson, William; Xiao, Han; Carlo, Maria I; Feldman, Darren R; Lee, Chung-Han; Motzer, Robert J; Voss, Martin H